KALIN KUBIAK: Open Payments
NPI 1821684424 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 32 payments from 8 companies in 2025. Trend: 2023 $782 · 2024 $836 · 2025 $1,158
Food & beverage: $1,158
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $308 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $307 |
| Novo Nordisk Inc | 16 | $247 |
| Sequel Med Tech, LLC | 1 | $146 |
| Tandem Diabetes Care, Inc. | 1 | $84 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Ascendis Pharma Endocrinology Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: MINIMED 780G, JARDIANCE, Ozempic, TWIIST, t:slim X2 Insulin Pump with Control-IQ, Wegovy, GVOKE HYPOPEN, Yorvipath.
Industry payments across MI — which companies pay providers there.
